Board Members and Executive Officers
Directors other than those who are Audit & Supervisory Committee Members
-
Toru Kimura
Representative Director, President and CEO
Career
-
April 1989
Joined Sumitomo Chemical Co., Ltd.
-
October 1992
Joined the former Sumitomo Pharmaceuticals Co., Ltd.
-
September 2013
Vice President, Head of the Regenerative & Cellular Medicine Office of the Company
-
April 2015
Executive Officer of the Company
-
June 2016
Member of the Board of Directors and Executive Officer of the Company
-
April 2019
Member of the Board of Directors and Managing Executive Officer of the Company
-
April 2021
Representative Director and Senior Managing Executive Officer of the Company
-
June 2024
Representative Director, President and CEO of the Company (up to the present)
-
-
Motoyuki Sakai
Representative Director, Executive Vice President
Global Corporate Strategy; Global Finance Administration
External Affairs; Corporate Governance; IT Management & Data AnalyticsCareer
-
April 1985
Joined Sumitomo Chemical Co., Ltd.
-
June 2007
General Manager, Finance & Accounting Office (Accounting) of Sumitomo Chemical Co., Ltd.
-
July 2010
General Manager, Corporate Planning & Coordination Office (Corporate Planning) of Sumitomo Chemical Co., Ltd.
-
April 2013
General Manager, Corporate Planning & Coordination Office (Business Development) of Sumitomo Chemical Co., Ltd.
-
April 2014
Executive Officer of Sumitomo Chemical Co., Ltd.
-
April 2018
Managing Executive Officer of Sumitomo Chemical Co., Ltd.
-
April 2018
President and Representative Director of Sumitomo Chemical Asia Pte Ltd
-
April 2023
Senior Managing Executive Officer of Sumitomo Chemical Co., Ltd.
-
June 2023
Representative Director and Senior Managing Executive Officer of Sumitomo Chemical Co., Ltd.
-
June 2024
Representative Director and Executive Vice President of the Company (up to the present)
-
-
Tsutomu Nakagawa
Member, Board of Directors, Managing Executive Officer
North America Business
President and CEO, Sumitomo Pharma America, Inc.Career
-
April 1993
Joined the former Sumitomo Pharmaceuticals Co., Ltd.
-
April 2016
Senior Officer of Global Oncology of the Company
-
April 2017
Senior Officer of Global Oncology (Development Strategy) of the Company
-
April 2019
Vice President, Head of the Global Oncology Office of the Company
-
April 2020
Vice President, Head of Global Corporate Strategy of the Company
-
April 2022
Executive Officer of the Company
-
July 2023
Chief Strategy Officer of Sumitomo Pharma America, Inc.
-
April 2024
President and CEO of Sumitomo Pharma America, Inc. (up to the present)
-
June 2024
Member of the Board of Directors and Executive Officer of the Company
-
April 2025
Member of the Board of Directors and Managing Executive Officer of the Company (up to the present)
-
-
Hiroshi Niinuma
Member, Board of Directors
Career
-
April 1981
Joined Sumitomo Chemical Co., Ltd.
-
April 2006
General Manager, Personnel Office of Sumitomo Chemical Co., Ltd.
-
April 2007
General Manager, Human Resources Department of Sumitomo Chemical Co., Ltd.
-
April 2009
General Manager, General Affairs Department of Sumitomo Chemical Co., Ltd.
-
April 2010
Executive Officer of Sumitomo Chemical Co., Ltd.
-
April 2013
Managing Executive Officer of Sumitomo Chemical Co., Ltd.
-
April 2018
Senior Managing Executive Officer of Sumitomo Chemical Co., Ltd.
-
June 2018
Director and Senior Managing Executive Officer of Sumitomo Chemical Co., Ltd.
-
April 2022
Director and Executive Vice President of Sumitomo Chemical Co., Ltd. (up to the present)
-
June 2024
Member of the Board of Directors of the Company (up to the present)
-
-
Minoru Usui
Member, Board of Directors (Outside)
Career
-
November 1979
Joined Shinshu Seiki Co., Ltd. (currently, Seiko Epson Corporation)
-
June 2002
Director of Seiko Epson Corporation
-
November 2005
General Administrative Manager of the Production Engineering & Development Division of Seiko Epson Corporation
-
July 2007
General Administrative Manager of the Corporate Research & Development Division of Seiko Epson Corporation
-
October 2007
Managing Director of Seiko Epson Corporation
-
June 2008
President and Representative Director of Seiko Epson Corporation, Chief Executive Officer of Seiko Epson Corporation
-
April 2020
Chairman and Director of Seiko Epson Corporation
-
June 2021
Member of the Board of Directors (Outside Director) of the Company (up to the present)
-
June 2021
Outside Director of IHI Corporation (up to the present)
-
-
Koji Fujimoto
Member, Board of Directors (Outside)
Career
-
April 1987
Joined the Ministry of International Trade and Industry (MITI)
(currently the Ministry of Economy, Trade and Industry (METI)) -
July 2003
Director of the Medical and Assistive Device Industries Office of METI
-
July 2008
Director of the Service Industries Division of METI (Director of the Healthcare Industries Division after organizational revision in July 2011)
-
July 2012
Counsellor of the Cabinet Secretariat (Office of Healthcare Policy, etc.)
-
July 2015
Councillor of the Cabinet Secretariat (Assistant Director of the Office of Healthcare Policy)
-
August 2019
Specially Appointed Professor at Tokyo Medical and Dental University (currently, Institute of Science Tokyo) (up to the present)
-
August 2019
Senior URA of the Research University Promotion Organization of Tokyo Medical and Dental University (currently, Institute of Science Tokyo)
-
August 2019
Deputy Director of the Research Center for Industry Alliances (the Open Innovation Center of the Institute of Research Innovation, after reorganization in March 2023) of Tokyo Medical and Dental University (currently, Institute of Science Tokyo)
-
June 2022
Member of the Board of Directors (Outside Director) of the Company (up to the present)
-
March 2023
Deputy Director/Senior URA of the Open Innovation Center of the Institute of Research Innovation of Tokyo Medical and Dental University (currently, Institute of Science Tokyo)
-
March 2023
Director of Emergency Assistance Japan Co., Ltd.
-
October 2024
Senior URA of the Center for Medical Innovation of Institute of Science Tokyo (up to the present)
-
March 2025
Advisor of Emergency Assistance Japan Co., Ltd. (up to the present)
-
Directors who are Audit & Supervisory Committee Members
-
Hisayoshi Kashima
Member, Board of Directors, Audit and Supervisory Committee Member
Career
-
April 1985
Joined the former Sumitomo Pharmaceuticals Co., Ltd.
-
June 2007
Vice President, Head of Finance & Accounting of the Company
-
April 2012
Member, Board of Directors of Sumitomo Pharma (Suzhou) Co., Ltd.
-
April 2014
Vice President, Head of Finance & Accounting of the Company
-
June 2023
Full-time Audit & Supervisory Board Member of the Company
-
June 2025
Directors who are Audit & Supervisory Committee Members (up to the present)
-
-
Yoshio Iteya
Member, Board of Directors, Audit and Supervisory Committee Member (Outside)
Career
-
April 1983
Admitted to the Bar (Japan)
-
April 1989
Admitted to the Bar (New York)
-
January 1992
Partner at Mori Hamada & Matsumoto
-
April 2004
Specially Appointed Professor at Hitotsubashi University School of Law (up to the present)
-
June 2018
Outside Audit & Supervisory Board Member of the Company
-
January 2021
Partner at Anderson Mori & Tomotsune (up to the present)
-
June 2024
Outside Audit & Supervisory Board Member of FUJIFILM Holdings Corporation (up to the present)
-
June 2025
Directors who are Audit & Supervisory Committee Members of the Company (up to the present)
-
-
Mayumi Mochizuki
Member, Board of Directors, Audit and Supervisory Committee Member (Outside)
Career
-
April 1976
Joined Nippon Roche K.K. (currently, Chugai Pharmaceutical Co., Ltd.)
-
April 1983
Joined the Department of Pharmacy of Kitasato University Hospital
-
April 1997
Associate Professor at the Graduate School of Pharmaceutical Sciences of Chiba University
-
September 2000
Professor at the School of Pharmacy of Kitasato University
-
April 2007
Professor at Kyoritsu University of Pharmacy
-
April 2008
Professor at the Faculty of Pharmacy of Keio University
-
April 2009
Associate Dean in Pharmacy at the Graduate School of Pharmaceutical Sciences of Keio University
-
July 2013
Dean of the Faculty of Pharmacy and Dean of the Graduate School of Pharmaceutical Sciences of Keio University
-
October 2015
Director of the Department of Pharmacy at Keio University Hospital
-
April 2019
Professor Emeritus at Keio University (up to the present)
-
April 2019
Project Professor at the Faculty of Pharmacy of Keio University
-
April 2019
Adviser of the International Medical Information Center (up to the present)
-
April 2020
Special Adviser of the International University of Health and Welfare
-
October 2020
Vice President of Science Council of Japan
-
June 2021
Outside Audit & Supervisory Board Member of the Company
-
June 2025
Directors who are Audit & Supervisory Committee Members of the Company (up to the present)
-
-
Daishiro Michimori
Member, Board of Directors, Audit and Supervisory Committee Member (Outside)
Career
-
April 1979
Joined the Ministry of Finance
-
October 2010
Councillor of the Cabinet Secretariat (National Policy Unit)
-
August 2012
Regional Commissioner of the Tokyo Regional Taxation Bureau
-
July 2014
Director-General for Policy Planning of the Ministry of Land, Infrastructure, Transport and Tourism
-
April 2016
Admitted to the Bar (Japan)
-
April 2016
Advisor Attorney of TMI Associates
-
April 2016
Managing Director of the Institute of Daiwa Institute of Research Ltd.
-
June 2016
Outside Member of the Board of World Co., Ltd.
-
April 2018
Senior Managing Director of the Institute of Daiwa Institute of Research Ltd.
-
April 2021
Visiting Attorney of Shimada Hamba & Osajima (up to the present)
-
April 2022
Senior Advisor of Daiwa Institute of Research Ltd.
-
June 2022
Outside Audit & Supervisory Board Member of the Company
-
June 2025
Directors who are Audit & Supervisory Committee Members of the Company (up to the present)
-
Executive Officers
-
Hideyuki Harada
Managing Executive Officer
Supply Chain Division
Senior Vice President, Head of Supply Chain Division
Head of Japan Business Unit
-
Yumi Sato
Managing Executive Officer
Research and Development Division
Senior Vice President, Head of Research and Development Division
Chief Development Officer, Sumitomo Pharma America, Inc.
-
Koichi Kozuki
Executive Officer
Business Development & Management;
Corporate Regulatory Compliance & Quality Assurance Division
Senior Vice President, Head of Corporate Regulatory Compliance & Quality Assurance Division
Deputy Head of Japan Business Unit
-
Isao Shimizu
Executive Officer
Senior Vice President, Deputy Head of Corporate Regulatory Compliance & Quality Assurance Division
Senior Vice President, Deputy Head of Research and Development Division (Drug Discovery Research)
-
Kenji Ueno
Executive Officer
Senior Vice President, Deputy Head of Research and Development Division (CMC)
-
Yutaka Wakemi
Executive Officer
Global Corporate Strategy; Global Finance -
Koji Yamazaki
Executive Officer
Sales & Marketing Division
Senior Vice President, Head of Sales & Marketing Division
Deputy Head of Japan Business Unit
-
Kimihiro Mizuno
Executive Officer
Legal & Compliance; Intellectual Property; Human Resources
Audit and Supervisory Special Officer
-
Takashi Kutsunai
Audit & Supervisory Special Officer